Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Corcept Therapeutics (CORT) over the last 12 years, with Q3 2025 value amounting to $13.5 million.

  • Corcept Therapeutics' Other Working Capital Changes rose 30414.01% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 86837.57%. This contributed to the annual value of -$5.4 million for FY2024, which is 14672.93% down from last year.
  • Latest data reveals that Corcept Therapeutics reported Other Working Capital Changes of $13.5 million as of Q3 2025, which was up 30414.01% from -$11.3 million recorded in Q2 2025.
  • Over the past 5 years, Corcept Therapeutics' Other Working Capital Changes peaked at $13.5 million during Q1 2025, and registered a low of -$11.3 million during Q2 2025.
  • Its 5-year average for Other Working Capital Changes is $1.7 million, with a median of $1.7 million in 2021.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 345560.17% in 2022, then tumbled by 74753.44% in 2025.
  • Over the past 5 years, Corcept Therapeutics' Other Working Capital Changes (Quarter) stood at $1.7 million in 2021, then tumbled by 437.95% to -$5.8 million in 2022, then skyrocketed by 203.75% to $6.0 million in 2023, then crashed by 49.54% to $3.0 million in 2024, then skyrocketed by 342.8% to $13.5 million in 2025.
  • Its last three reported values are $13.5 million in Q3 2025, -$11.3 million for Q2 2025, and $13.5 million during Q1 2025.